ChrisCarol Bremer

Executive Vice President Early Products and Commercial Opportunities at Grünenthal Group - Worthington, IA, US

ChrisCarol Bremer's Colleagues at Grünenthal Group
Stefan Bluemmers

SVP Head New Products Latin America

Contact Stefan Bluemmers

Carole Masuy

Business Insights & CRM Manager EU-CD, EU-Commercial Development

Contact Carole Masuy

Carlos Pereira

National Key Account Manager

Contact Carlos Pereira

Rute Osorio

Head Of Regulatory Compliance&Excellence

Contact Rute Osorio

Rita Pereira

Hospital Sales Specialist

Contact Rita Pereira

View All ChrisCarol Bremer's Colleagues
ChrisCarol Bremer's Contact Details
HQ
49-241-569-0
Location
Melbourne, Victoria, Australia
Company
Grünenthal Group
ChrisCarol Bremer's Company Details

Grünenthal Group

Worthington, IA, US • 1000 - 4999 Employees
Major Drugs

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: www.grunenthal.com. Search fields for Licensing & Acquisition R&D (from late preclinical to late stage clinical development, focus on small indications, clear differentiation vs. standard of care) Perioperative care Inflammation (niches in rheumatic diseases and other inflammatory diseases) Niche indication and rare diseases Cancer Supportive Care Europe (marketed RX-products for the retail- and or / or hospital business) Pain Perioperative Care Inflammation Neurology/Psychiatry Cancer Supportive Care Bone disorders Movement disorders Latin America (marketed RX-products for the retail- and or / or hospital business) Urology Gynecology Pain Inflammation Neurology/Psychiatry Cancer Supportive Care Grünenthal's Innovative Medicines Unit: www.imu.grunenthal.com Grünenthal's innovative INTAC® technology: www.intac.grunenthal.com Jobs & Career: http://www.grunenthal.com/grt-web/Grunenthal_Group/Jobs-Career/Vacancies/134100187.jsp Imprint: http://grunenthal.com/grt-web/Grunenthal_Group/Service/Imprint/130200018.jsp

Europe: Pain (prescriptive drugs) Further indications Latin America: Pain Central Nervous System Gynecology Further indications R&D: Pain Inflammation
Details about Grünenthal Group
Frequently Asked Questions about ChrisCarol Bremer
ChrisCarol Bremer currently works for Grünenthal Group.
ChrisCarol Bremer's role at Grünenthal Group is Executive Vice President Early Products and Commercial Opportunities.
ChrisCarol Bremer's email address is ***@grunenthal.com. To view ChrisCarol Bremer's full email address, please signup to ConnectPlex.
ChrisCarol Bremer works in the Pharmaceuticals industry.
ChrisCarol Bremer's colleagues at Grünenthal Group are Stefan Bluemmers, Carole Masuy, Ann Hoebeke, Ana Martins, Carlos Pereira, Rute Osorio, Rita Pereira and others.
ChrisCarol Bremer's phone number is 49-241-569-0
See more information about ChrisCarol Bremer